VEGFA and glioblastoma: Similarly, our lab recently showed that bevacizumab, an anti-angiogenic therapeutic designed to inhibit VEGF signalling, could be encapsulated by GBM cells and presented at the surface of EVs secreted by the respective GBM cells.